Navigation Links
Alzheimer's Disease Neuroimaging Initiative announces completion of genome-wide analysis
Date:3/16/2009

INDIANAPOLIS Researchers announced today that a high-density genome wide analysis of participants in the Alzheimer's Disease Neuroimaging Initiative (ADNI; www.adni-info.org) is more than 95% complete and that data will be shared with scientists around the world for further analysis.

The ADNI data will be used by researchers to search for genes that contribute to the development of Alzheimer's disease, which currently affects up to 5 million people in the United States alone.

ADNI, an ongoing $60 million project, is a public-private partnership supported primarily by the National Institutes of Health (NIH) with pharmaceutical and related industries and not-for-profit organizations providing support through the Foundation for the National Institutes of Health (FNIH). One of the largest scale neuroimaging projects ever undertaken, ADNI involves longitudinal magnetic resonance imaging (MRI) and positron emission tomography (PET) brain imaging and blood, urine and spinal fluid biomarker studies of more than 800 individuals, half of whom have mild cognitive impairment, a condition placing them at high risk for developing Alzheimer's disease or another dementia.

The primary goal of ADNI is to determine whether brain imaging, other biological markers, and clinical and neuropsychological assessment can accurately measure the progression of mild cognitive impairment and early Alzheimer's disease. The identification of specific biomarkers of early Alzheimer's disease and disease progression will provide a useful tool for researchers and clinicians in both the diagnosis of early Alzheimer's disease and in the development, assessment and monitoring of new treatments.

One major Alzheimer's disease risk gene, APOE, has been consistently shown to be associated with the form of the disease arising later in life that accounts for approximately 95 percent of all cases. It is widely suspected that variants in an ensemble of other genes play a
'/>"/>

Contact: Eric B. Schoch
eschoch@iupui.edu
317-274-7722
Indiana University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. University of Notre Dame Chooses Latest Technology From Carestream Molecular Imaging For Disease Research
3. Project Runway Designer in Houston to Educate About Living With HIV and Combat Stigma Associated With the Disease
4. Drugs Before Stents for Stable Heart Disease, Study Says
5. Aspirin improves survival in women with stable heart disease, according to WHI study
6. 23andMe Launches Parkinsons Disease Genetics Initiative
7. Michael J. Fox Foundation Joins Effort to Recruit 10,000 People With Parkinsons Disease to New Web-Based PD Research Community
8. Genes May Decide Which Smokers Get Lung Disease
9. Kidney Care Partners and National Minority Quality Forum Call for Prevention Programs in Disease Hot Spots
10. Overweight Preschoolers Raise Their Heart Disease Risk
11. Malaria Drug Doesnt Boost Survival Odds With Prion Diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...n Sunday, more than 900 runners and walkers from L...ish line at the Rock ‘n’ Roll Las Vega...r $3.2 million for the Crohn,s & Colitis Found...Team Challenge (www.ccteamchallenge). As the offic...research, education, and support initiatives to be...
(Date:12/2/2009)... The American Health In...ors today announced Alan F. Dowling, PhD, will be ...th information management (HIM) leader. Dr. Dowli...des academia, systems management, strategic expert...xecutive leadership. He is scheduled to take offi...
(Date:12/2/2009)...Dec. 2 Pro-abortion act...r 2 in their campaign against the U.S. House bill,...s United for Life President and CEO Charmaine Yoes...ion lobby,s effort to expand taxpayer funding of a...care, the feminist groups and the abortion lobby a...
(Date:12/2/2009)... Washington Post Highlights Dangers ,, W... the Catholic bishops have their way, many medical...granted may be under threat. The pressure that th...er healthcare reform has been widely reported. An ...e likely impact if that pressure to influence heal...
(Date:12/2/2009)... /PRNewswire/ -- The Universities of Sassari and... team of doctors from the United States, announced...dy confirming that Pecorino cheese contains high a...-6 polyunsaturated fatty acid naturally found in c...erties for humans. ,, The study, conducted in...
Breaking Medicine News(10 mins):Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 3
...nto the car and heading towards the highway. At ti...vomiting . This means some passengers have a bout ...ness, a variant of motion sickness, happens when t...at Lucille Packard Children's Hospital at Stanford...
...ptoms of mental retardation and autism in mice for...by a team of researchers including Mansuo L. Hayas...r Learning and Memory at MIT. As part of t...ommon genetic cause of autism. The conditi...
...ll in England, both in terms of lives and money n... a report published today by the All Party Parliam... Wasted Money, Wasted Lives - concludes that, desp...re taking anti-epilepsy drugs they do not need. ...
... agreement with Delmont Laboratory to introduce it...reats diseases of staphylococcal infection . Accor... will supply bulk materials and China Biopharma wi... This product requires a clinical study and an app...
...from its Phase IIb study in Alzheimer's disease (A...y be thought of and treated as diabetes of the bra... the accumulation of amyloid beta plaques in the b...and pathological symptoms of AD. AD may therefore ...
...completed its acquisition of BioVeris. Roche signe...tely $600 million on April 4, 2007. This ...lectrochemiluminescence (ECL) technology and can e... patient self-testing, veterinary testing, drug di...
Other Medicine News:Health News:Car Sickness for the Little Ones can Be Prevented 2Health News:Car Sickness for the Little Ones can Be Prevented 3Health News:Researchers Reverse Mental Retardation Symptoms in Mice 2Health News:Blunders in Epilepsy Care Cost Lives, and Money UK Report 2Health News:Experimental Drug Ketasyn(TM) (AC-1202) Treats Alzheimer's as Diabetes of the Brain 2
(Date:12/2/2009)...EIDELBERG, Germany, Dec. 2 febit,s...rs of the "Top 10 Innovations of 2009" by The Sci... capture technology for high-throughput sequencing...of invention, vision and utility. ,, The Scie...te a broad range of life science technologies and ...
(Date:12/2/2009)... TeamHealth Teleradiology ( www.th...rgest provider of hospital-based clinical outsourc...ide teleradiology services for two groups in South...with UpState Carolina Radiology located in Spartan... provide services for the following four hospitals...
(Date:12/2/2009)...RNewswire/ -- Decision Resources, one of the world...eutical and healthcare issues, finds that generic ...tipsychotics will cause the schizophrenia drug mar...billion in 2013 in the United States, France, Germ..., The new Pharmacor report entitled Schizophre...
Breaking Medicine Technology:The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2Outsmarting Brain Tumors 3A Cedars Sinai Researchers Neurosurgeons and Other Experts Present Free Conference for Adult Brain Tumor Patients and Careg 47564 1Outsmarting Brain Tumors 3A Cedars Sinai Researchers Neurosurgeons and Other Experts Present Free Conference for Adult Brain Tumor Patients and Careg 47564 2Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative 4510 1Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative 4510 2Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative 4510 3Nature parks can save species as climate changes 12401 1Nature parks can save species as climate changes 12401 2Nature parks can save species as climate changes 12401 3
...AMBRIDGE, England, 4th May 2007 - CeNeS Pharmaceut...aceutical company, notes,the publication of an ind... ,Synapse,* on its Phase II NMDA antagonist, CNS 5...reatment for neuropathic,pain. The independent stu...taken with CNS 5161. , In the study reported in ,S...
...mpany Conference Call Scheduled for Friday, May 4,...ANCISCO, May 03, 2007 /PRNewswire-FirstCall/ --,Me...the mild and,moderate subgroups of Alzheimer,s dis...fficacy study of Dimebon showed that both,subgroup...ents on,all five efficacy endpoints studied. , The...
Other Medicine Technology:Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5
MAMMOMAT 3000 Nova Mammography System
ActiveLife® One-Piece Cut-to-Fit Urostomy Pouch With Stomahesive® Skin Barrier
Contour I Drainable Pouch, Oval Cut-to-Fit Skin Barrier
Karaya 5 Drainable Pouch, 9in., (23cm)
Medicine Products: